Medicare Enrolled
Dr. Peyman Salimi-Tari, M.D.
Hematology & Oncology · Fountain Valley, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Salimi-Tari from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Salimi-Tari?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Salimi-Tari
Dr. Peyman Salimi-Tari is a hematology & oncology specialist in Fountain Valley, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Salimi-Tari performed 4,098 Medicare services across 446 unique beneficiaries.
Between the years covered by Open Payments, Dr. Salimi-Tari received a total of $44,793 from 118 pharmaceutical and/or device companies across 2052 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Salimi-Tari is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 34% volume in CA
$44,793 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,098
Medicare services
Top 34% in CA for hematology & oncology
446
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~216 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (ondansetron/Zofran) | 1,548 | $0 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,126 | $0 | $5 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
386 | $141 | $300 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
240 | $118 | $290 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
144 | $26 | $75 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
138 | $103 | $250 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
128 | $14 | $55 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
100 | $100 | $225 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
96 | $1 | $15 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
77 | $7 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
52 | $70 | $125 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
28 | $55 | $150 |
| New patient office visit, complex (60-74 min) | 19 | $170 | $375 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
16 | $145 | $330 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.1% high complexity
72.6% medium
17.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$44,793
Total received (2018-2024)
Avg $6,399/year across 7 years
Top 12% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
118
Companies
2,052
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$37,837 (84.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,261 (11.7%)
Other
Charitable contributions, space rental, and other categories
$1,501 (3.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$194 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$9,338
2023
$6,010
2022
$6,229
2021
$5,389
2020
$9,466
2019
$4,487
2018
$3,874
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,501
Alexion Pharmaceuticals, Inc.
$607
AstraZeneca Pharmaceuticals LP
$488
Merck Sharp & Dohme LLC
$467
Eisai Inc.
$424
Takeda Pharmaceuticals U.S.A., Inc.
$407
PFIZER INC.
$386
Janssen Biotech, Inc.
$365
Incyte Corporation
$338
Celgene Corporation
$332
ABBVIE INC.
$295
PUMA BIOTECHNOLOGY, INC.
$245
Stemline Therapeutics Inc.
$221
Gilead Sciences, Inc.
$214
BeiGene USA, Inc.
$212
Regeneron Healthcare Solutions, Inc.
$194
Daiichi Sankyo Inc.
$193
E.R. Squibb & Sons, L.L.C.
$187
Astellas Pharma US Inc
$180
GlaxoSmithKline, LLC.
$164
Sumitomo Pharma America, Inc.
$147
GENZYME CORPORATION
$146
SOBI, INC
$142
EMD Serono, Inc.
$128
Blueprint Medicines Corporation
$120
Bayer Healthcare Pharmaceuticals Inc.
$118
Exelixis Inc.
$114
Lilly USA, LLC
$89
Genentech USA, Inc.
$89
Ipsen Biopharmaceuticals, Inc
$79
JAZZ PHARMACEUTICALS INC.
$68
Rigel Pharmaceuticals, Inc.
$68
PharmaEssentia USA Corporation
$58
TAIHO ONCOLOGY, INC.
$40
ARRAY BIOPHARMA INC
$40
RECORDATI_RARE_DISEASES_INC.
$38
Fennec Pharmaceuticals, Inc.
$31
Immunocore Limited
$30
Tempus AI, Inc
$29
Karyopharm Therapeutics Inc.
$29
Genmab U.S., Inc.
$29
Legend Biotech USA Inc.
$28
SpringWorks Therapeutics, Inc.
$27
Aveo Pharmaceuticals, Inc.
$26
Alnylam Pharmaceuticals Inc.
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
Geron Corporation
$24
Agios Pharmaceuticals, Inc.
$24
Myriad Genetic Laboratories, Inc.
$24
Coherus Biosciences Inc.
$22
SERVIER PHARMACEUTICALS LLC
$22
MorphoSys, US Inc.
$21
Acrotech Biopharma Inc.
$17
Top 3 companies account for 27.8% of 2024 payments
All-time payments by company (2018-2024) ›
Kite Pharma, Inc.
$5,488
Novartis Pharmaceuticals Corporation
$3,540
Janssen Biotech, Inc.
$2,309
AstraZeneca Pharmaceuticals LP
$2,227
Incyte Corporation
$2,091
Amgen Inc.
$1,543
Celgene Corporation
$1,502
PFIZER INC.
$1,456
E.R. Squibb & Sons, L.L.C.
$1,444
Merck Sharp & Dohme LLC
$1,095
Merck Sharp & Dohme Corporation
$1,050
Eisai Inc.
$1,037
Pharmacyclics LLC, An AbbVie Company
$969
Takeda Pharmaceuticals U.S.A., Inc.
$964
Alexion Pharmaceuticals, Inc.
$881
Genentech USA, Inc.
$867
Seagen Inc.
$798
Exelixis Inc.
$748
Gilead Sciences, Inc.
$734
GlaxoSmithKline, LLC.
$689
Daiichi Sankyo Inc.
$627
Bayer HealthCare Pharmaceuticals Inc.
$585
Astellas Pharma US Inc
$556
Regeneron Healthcare Solutions, Inc.
$547
Lilly USA, LLC
$490
Boehringer Ingelheim Pharmaceuticals, Inc.
$485
PUMA BIOTECHNOLOGY, INC.
$456
EMD Serono, Inc.
$431
Stemline Therapeutics Inc.
$365
GENZYME CORPORATION
$361
NOVARTIS PHARMACEUTICALS CORPORATION
$339
Myovant Sciences Inc.
$336
ABBVIE INC.
$315
BeiGene USA, Inc.
$313
Karyopharm Therapeutics Inc.
$284
Coherus Biosciences Inc.
$278
EISAI INC.
$276
Blueprint Medicines Corporation
$275
Rigel Pharmaceuticals, Inc.
$273
Sumitomo Pharma America, Inc.
$253
AbbVie Inc.
$252
Bayer Healthcare Pharmaceuticals Inc.
$220
Ipsen Biopharmaceuticals, Inc
$194
AbbVie, Inc.
$189
Puma Biotechnology, Inc.
$171
SOBI, INC
$166
Agios Pharmaceuticals, Inc.
$165
MorphoSys, US Inc.
$164
AVEO Pharmaceuticals, Inc.
$149
Seattle Genetics, Inc.
$147
Array BioPharma Inc.
$146
Foundation Medicine, Inc.
$146
Teva Pharmaceuticals USA, Inc.
$142
JAZZ PHARMACEUTICALS INC.
$141
Taiho Oncology, Inc.
$140
ARRAY BIOPHARMA INC
$139
TerSera Therapeutics LLC
$135
SERVIER PHARMACEUTICALS LLC
$130
AMAG Pharmaceuticals, Inc.
$109
Deciphera Pharmaceuticals Inc.
$106
Pharmacyclics LLC, an AbbVie Company
$104
Ethicon Inc.
$96
Organon LLC
$94
Mylan Institutional Inc.
$93
ADC Therapeutics America, Inc.
$89
Octapharma USA, Inc.
$74
Epizyme, Inc.,
$71
Adaptive Biotechnologies Corporation
$66
Clovis Oncology, Inc.
$65
Dendreon Pharmaceuticals LLC
$63
Otsuka America Pharmaceutical, Inc.
$63
RECORDATI_RARE_DISEASES_INC.
$62
PharmaEssentia USA Corporation
$58
MEDIVATION FIELD SOLUTIONS LLC
$58
Pharmacosmos Therapeutics Inc.
$55
TAIHO ONCOLOGY, INC.
$54
Genmab U.S., Inc.
$53
Lexicon Pharmaceuticals, Inc.
$51
Sobi, Inc
$50
TESARO, Inc.
$48
Dova Pharmaceuticals
$47
Spectrum Pharmaceuticals Inc.
$45
Aveo Pharmaceuticals, Inc.
$44
Sirtex Medical Inc
$44
ImmunoGen, Inc.
$43
Novocure Inc.
$39
Servier Pharmaceuticals LLC
$35
Jazz Pharmaceuticals Inc.
$33
Partner Therapeutics, Inc.
$33
Acrotech Biopharma Inc.
$32
Fennec Pharmaceuticals, Inc.
$31
Boston Scientific Corporation
$30
Immunocore Limited
$30
Tempus AI, Inc
$29
Legend Biotech USA Inc.
$28
SpringWorks Therapeutics, Inc.
$27
EUSA Pharma (US) LLC
$27
Alnylam Pharmaceuticals Inc.
$26
Geron Corporation
$24
Myriad Genetic Laboratories, Inc.
$24
Verity Pharmaceuticals Inc.
$24
Sun Pharmaceutical Industries Inc.
$23
CTI BioPharma Corp.
$23
GE HealthCare
$23
Secura Bio, Inc.
$23
Kyowa Kirin, Inc.
$20
Heron Therapeutics, Inc.
$20
West Therapeutics Development, LLC
$18
Immunomedics, Inc.
$18
TG Therapeutics, Inc.
$18
G1 Therapeutics, Inc.
$18
Helsinn Therapeutics (U.S.), Inc.
$18
Acrotech Biopharma LLC
$16
Chiesi USA, Inc.
$14
GE HEALTHCARE
$13
CHIESI USA, INC.
$13
APO-PHARMA USA, INC.
$13
Mylan Pharmaceuticals Inc.
$11
Top 3 companies account for 25.3% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALTUVIIIO · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · Asparlas · Avastin · BALVERSA · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CHANTIX · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · EXKIVITY · Elahere · Enhertu · Epkinly · Erleada · FARYDAK · FERAHEME · FERRIPROX · FERRIPROX 500ML BOTTLE · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE HEME · FRUZAQLA · Fabhalta · Farydak · Folotyn · Fulphila · GAMIFANT · GAVRETO · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lazanda · Lenvima · Leukine · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · Monarch Platform · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORENCIA · ORGOVYX · OXBRYTA · OXLUMO · Oncology · Onivyde · Optune · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pedmark · Perjeta · Pomalyst · Prolia · QINLOCK · Quzyttir · REBLOZYL · RYDAPT · RYTELO · Revlimid · Rezlidhia · Rituxan Hycela · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · SYNAGIS · Somatuline Depot · Stivarga · Sylvant · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · TheraSphere Y90 Glass Microspheres 10 GBq · Tibsovo · Trelstar · Trodelvy · Truxima · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Vanflyta · Vectibix · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (84%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
208
Per 100K population
6.6
County median income
$113,702
Nearest hospital
UCI HEALTH - FOUNTAIN VALLEY
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Salimi-Tari is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 12% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Salimi-Tari experienced with anti-nausea injection (ondansetron/zofran)?
Based on Medicare claims data, Dr. Salimi-Tari performed 1,548 anti-nausea injection (ondansetron/zofran) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Salimi-Tari receive payments from pharmaceutical companies?
Yes. Dr. Salimi-Tari received a total of $44,793 from 118 companies across 2,052 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Salimi-Tari's costs compare to other hematology & oncology specialists in Fountain Valley?
Dr. Salimi-Tari's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Salimi-Tari) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Fountain Valley
Browse hematology & oncology specialists in Fountain Valley ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Kite Pharma, Inc. Payments to Doctors
See all physicians who received payments from Kite Pharma, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology